Ethnically diverse pluripotent stem cells for drug development.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Trends in Molecular Medicine

• Publication date

  2012-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molmed.2012.10.007PMID 23142148
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Generation, characterization and potential therapeutic applications of mature and functional hepatocytes from stem cells

  2013cited by this paper
• Rapid generation of mature hepatocyte‐like cells from human induced pluripotent stem cells by an efficient three‐step protocol

  2012cited by this paper
• Self-renewing endodermal progenitor lines generated from human pluripotent stem cells.

  2012cited by this paper
• Using genome-wide association studies to identify genes important in serious adverse drug reactions.

  2012cited by this paper
• Modeling hepatitis C virus infection using human induced pluripotent stem cells

  2012cited by this paper
• Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types.

  2012cited by this paper
• Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.

  2012cited by this paper
• Highly efficient generation of definitive endoderm lineage from human induced pluripotent stem cells.

  2012cited by this paper
• The Role of Human Leukocyte Antigen Matching in the Development of Multiethnic “Haplobank” of Induced Pluripotent Stem Cell Lines

  2012cited by this paper
• Copy number variants in pharmacogenetic genes.

  2011cited by this paper
• New Approaches in the Differentiation of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells toward Hepatocytes

  2011cited by this paper
• Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial

  2011cited by this paper
• Expression of albumin and cytochrome P450 enzymes in HepG2 cells cultured with a nanotechnology-based culture plate with microfabricated scaffold.

  2011cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

  2011cited by this paper
• Differentiation and Transplantation of Human Induced Pluripotent Stem Cell-derived Hepatocyte-like Cells

  2011cited by this paper
• Screening ethnically diverse human embryonic stem cells identifies a chromosome 20 minimal amplicon conferring growth advantage

  2011cited by this paper
• Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450–2C19 (CYP2C19) Genotype and Clopidogrel Therapy

  2011cited by this paper
• A more efficient method to generate integration-free human iPS cells

  2011cited by this paper
• CORRIGENDUM: Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing

  2011cited by this paper
• In Vivo Liver Regeneration Potential of Human Induced Pluripotent Stem Cells from Diverse Origins

  2011cited by this paper
• Human Stem Cell Manual: A Laboratory Guide

  2011cited by this paper
• Generation of endoderm‐derived human induced pluripotent stem cells from primary hepatocytes

  2010cited by this paper
• Role of Human Liver Microsomes in In Vitro Metabolism of Drugs—A Review

  2010cited by this paper
• Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development

  2010cited by this paper
• From skin cells to hepatocytes: advances in application of iPS cell technology.

  2010cited by this paper
• Highly efficient generation of human hepatocyte–like cells from induced pluripotent stem cells

  2010cited by this paper
• Human pluripotent stem cells in drug discovery and predictive toxicology.

  2010cited by this paper
• Differentiation and Characterization of Metabolically Functioning Hepatocytes from Human Embryonic Stem Cells

  2010cited by this paper
• Genetic and ethnic risk factors associated with drug hypersensitivity

  2010cited by this paper
• A Combining Method to Enhance the In Vitro Differentiation of Hepatic Precursor Cells

  2010cited by this paper
• Lack of population diversity in commonly used human embryonic stem-cell lines.

  2010cited by this paper
• Preempting and preventing drug-induced liver injury

  2010cited by this paper
• Restricted ethnic diversity in human embryonic stem cell lines

  2010cited by this paper
• Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells

  2009cited by this paper
• HLA-matching potential of an established human embryonic stem cell bank in China.

  2009cited by this paper
• Global gene expression changes including drug metabolism and disposition induced by three-dimensional culture of HepG2 cells-Involvement of microtubules.

  2009cited by this paper
• Generation of functional human hepatic endoderm from human induced pluripotent stem cells

  2009cited by this paper
• Expedited growth factor-mediated specification of human embryonic stem cells toward the hepatic lineage.

  2009cited by this paper
• Liver cell culture techniques.

  2009cited by this paper
• Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.

  2009cited by this paper
• Clinical pharmacogenetics and potential application in personalized medicine.

  2008cited by this paper
• Multiple Advantageous Amino Acid Variants in the NAT2 Gene in Human Populations

  2008cited by this paper
• Efficient Differentiation of Hepatocytes from Human Embryonic Stem Cells Exhibiting Markers Recapitulating Liver Development In Vivo

  2008cited by this paper
• Differentiation of mouse and human embryonic stem cells into hepatic lineages

  2008cited by this paper
• Isoniazid and its toxic metabolite hydrazine induce in vitro pyrazinamide toxicity.

  2008cited by this paper
• Efficient Differentiation of Functional Hepatocytes from Human Embryonic Stem Cells

  2008cited by this paper
• Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose.

  2008cited by this paper
• Induction of pluripotent stem cells from adult human fibroblasts by defined factors.

  2007cited by this paper
• Development of an in vitro assay for the investigation of metabolism-induced drug hepatotoxicity

  2007cited by this paper
• A high-throughput cell-based toxicity analysis of drug metabolites using flow cytometry

  2007cited by this paper
• Direct Differentiation of Human Embryonic Stem Cells to Hepatocyte-like Cells Exhibiting Functional Activities

  2007cited by this paper
• Directed differentiation of human embryonic stem cells into functional hepatic cells

  2007cited by this paper
• High-resolution HLA alleles and haplotypes in the United States population.

  2007cited by this paper
• Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: Implication for optimization of breast cancer treatment

  2006cited by this paper
• Validation of in vitro cell models used in drug metabolism and transport studies; genotyping of cytochrome P450, phase II enzymes and drug transporter polymorphisms in the human hepatoma (HepG2), ovarian carcinoma (IGROV-1) and colon carcinoma (CaCo-2, LS180) cell lines.

  2006cited by this paper
• Differentiation of human embryonic stem cells into hepatocytes in 2D and 3D culture systems in vitro.

  2006cited by this paper
• Predictions of the In Vivo Clearance of Drugs from Rate of Loss Using Human Liver Microsomes for Phase I and Phase II Biotransformations

  2006cited by this paper
• Pharmacological Characterization of 4-hydroxy-N-desmethyl Tamoxifen, a Novel Active Metabolite of Tamoxifen

  2004cited by this paper
• Influence of culture time on the expression of drug‐metabolizing enzymes in primary human hepatocytes and hepatoma cell line HepG2

  2003cited by this paper
• Development of a novel in vitro model to predict hepatic clearance using fresh, cryopreserved, and sandwich-cultured hepatocytes.

  2002cited by this paper
• Isoniazid is a mechanism-based inhibitor of cytochrome P450 1A2, 2A6, 2C19 and 3A4 isoforms in human liver microsomes

  2001cited by this paper
• Pharmacogenomics, ethnicity, and susceptibility genes

  2001cited by this paper
• Pharmacogenomics: translating functional genomics into rational therapeutics.

  1999cited by this paper
• 10‐hydroxylation of nortriptyline in white persons with 0, 1, 2, 3, and 13 functional CYP2D6 genes

  1998cited by this paper
• Drug-induced hepatotoxicity.

  1995cited by this paper
• Evolution of a highly polymorphic human cytochrome P450 gene cluster: CYP2D6.

  1992cited by this paper
• Drug metabolising N-acetyltransferase activity in human cell lines.

  1991cited by this paper

• Bringing African ancestry into cellular neuroscience

  2026cites this paper
• Stem Cell Therapies Approach for Treating Cancers: Opportunity Progress and Challenges

  2024cites this paper
• Overcoming the Variability of iPSCs in the Manufacturing of Cell-Based Therapies

  2023cites this paper
• Automated Sarcomere Structure Analysis for Studying Cardiotoxicity in Human Pluripotent Stem Cell-Derived Cardiomyocytes

  2022cites this paper
• The Promoting Equity in Stem Cell Genomics Survey.

  2022cites this paper
• Future stem cell analysis: progress and challenges towards state-of-the art approaches in automated cells analysis

  2022cites this paper
• Leveraging the genetic diversity of human stem cells in therapeutic approaches.

  2021cites this paper
• Human OMICs and Computational Biology Research in Africa: Current Challenges and Prospects

  2021cites this paper
• Applications for stem cells

  2020cites this paper
• Automated image analysis system for studying cardiotoxicity in human pluripotent stem cell-Derived cardiomyocytes

  2020cites this paper
• Induced Pluripotent Stem Cells

  2019cites this paper
• Pluripotent Stem Cell Heterogeneity: Clonal Isolation of Human Pluripotent Stem Cells on Nanofibrous Substrates Reveals an Advanced Subclone for Cardiomyocyte Differentiation (Adv. Healthcare Mater. 13/2019)

  2019cites this paper
• Pharmacokinetics, Pharmacodynamics, and Toxicities: What Should We Know About Genetic Factors that Affect the Pharmacotherapy of Pulmonary Diseases?

  2018cites this paper
• Stem Cells and Commercialization

  2016cites this paper
• The Importance of Recruiting a Diverse Population for Stem Cell Clinical Trials

  2016cites this paper
• Application of Pluripotent Stem Cells in Drug‐Induced Liver Injury Safety Assessment

  2016cites this paper
• Use of Induced Pluripotent Stem Cells in Drug Toxicity Screening

  2014cites this paper
• Chapter 11 – Stem Cells

  2014cites this paper
• How multi-organ microdevices can help foster drug development.

  2014cites this paper
• Integrating human pluripotent stem cells into drug development.

  2013cites this paper
• Monocrotophos in Gandaman village: India school lunch deaths and need for improved toxicity testing

  2013cites this paper